VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $718,548 | -62.4% | 43,156 | -78.8% | 0.16% | -64.6% |
| Q4 2022 | $1,909,666 | +51.6% | 203,156 | -56.1% | 0.46% | +83.7% |
| Q3 2022 | $1,260,000 | -47.8% | 463,156 | -44.6% | 0.25% | -43.0% |
| Q2 2022 | $2,414,000 | +51.3% | 835,275 | +56.9% | 0.44% | +109.5% |
| Q1 2022 | $1,596,000 | -30.7% | 532,429 | +6.3% | 0.21% | -38.8% |
| Q4 2021 | $2,303,000 | -26.7% | 500,642 | 0.0% | 0.34% | +55.2% |
| Q3 2021 | $3,144,000 | 0.0% | 500,642 | -4.6% | 0.22% | -13.0% |
| Q2 2021 | $3,144,000 | -31.4% | 524,754 | -27.6% | 0.25% | +64.9% |
| Q1 2021 | $4,584,000 | +57200.0% | 724,754 | +62432.7% | 0.15% | +15300.0% |
| Q2 2020 | $8,000 | -98.6% | 1,159 | -99.1% | 0.00% | -97.7% |
| Q1 2020 | $590,000 | -82.7% | 126,159 | -70.4% | 0.04% | -92.1% |
| Q4 2019 | $3,418,000 | – | 426,159 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |